Riken Vitamin Co., Ltd. (4526.T)
JPY 2408.0
(-1.23%)
JPY 2408.0
(-1.23%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 91.48 Billion | 88.75 Billion | 79.23 Billion | 77.72 Billion | 82.97 Billion | 89.88 Billion |
| Cost of Revenue | 61.85 Billion | 61.5 Billion | 53.66 Billion | 55.71 Billion | 55.51 Billion | 63.51 Billion |
| Gross Profit | 29.62 Billion | 27.24 Billion | 25.56 Billion | 22.01 Billion | 27.45 Billion | 26.37 Billion |
| Operating Expenses | 20.51 Billion | 20.08 Billion | 19.72 Billion | 20.64 Billion | 21.06 Billion | 21.32 Billion |
| Selling, General and Administrative Expenses | 16.94 Billion | 16.67 Billion | 16.51 Billion | 17.31 Billion | 17.66 Billion | 18.16 Billion |
| Research and Development Expenses | 3.31 Billion | 3.22 Billion | 2.99 Billion | 3.09 Billion | 3.08 Billion | 2.87 Billion |
| Other Expenses | 259 Million | 149 Million | 104 Million | 252 Million | 54 Million | 52 Million |
| Cost and Expenses | 82.11 Billion | 81.59 Billion | 73.38 Billion | 76.35 Billion | 76.58 Billion | 84.83 Billion |
| Operating Income | 9.37 Billion | 7.15 Billion | 5.84 Billion | 1.36 Billion | 6.38 Billion | 5.05 Billion |
| Interest Expense | 112 Million | 132 Million | 178 Million | 665 Million | 727 Million | 756 Million |
| Income Tax Expense | 3.14 Billion | 1.44 Billion | -1.28 Billion | 1.6 Billion | 1.9 Billion | 2.07 Billion |
| Earnings before Tax | 11.9 Billion | 7.85 Billion | 20.31 Billion | -7 Million | -5.89 Billion | 6.04 Billion |
| Net Income | 8.75 Billion | 6.41 Billion | 21.58 Billion | -1.61 Billion | -7.85 Billion | 3.94 Billion |
| Earnings Per Share Basic | 268.44 | 195.51 | 657.98 | -49.34 | -239.45 | 120.46 |
| Earnings Per Share Diluted | 268.42 | 195.51 | 657.98 | -49.34 | -239.45 | 120.46 |
| Weighted Average Shares Outstanding | 32.61 Million | 32.8 Million | 32.79 Million | 32.79 Million | 32.78 Million | 32.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.61 Million | 32.8 Million | 32.8 Million | 32.79 Million | 32.78 Million | 32.78 Million |
| Gross Margin | 0.32 | 0.31 | 0.32 | 0.28 | 0.33 | 0.29 |
| EBIT Margin | 0.14 | 0.13 | 0.13 | 0.08 | 0.13 | 0.10 |
| Profit Margin | 0.10 | 0.07 | 0.27 | -0.02 | -0.09 | 0.04 |
| EBITDA | 12.7 Billion | 10.84 Billion | 9.57 Billion | 5.32 Billion | -2.18 Billion | 8.49 Billion |
| Earnings Before Tax Margin | 0.10 | 0.08 | 0.07 | 0.02 | 0.08 | 0.06 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 23.62 Billion | 91.48 Billion | 22.42 Billion | 24.44 Billion | 22.42 Billion | 22.18 Billion |
| Cost of Revenue | 15.6 Billion | 61.85 Billion | 15.22 Billion | 16.31 Billion | 15.22 Billion | 14.84 Billion |
| Gross Profit | 8.02 Billion | 29.62 Billion | 7.2 Billion | 8.13 Billion | 7.2 Billion | 7.34 Billion |
| Operating Expenses | 5.5 Billion | 20.25 Billion | 5.49 Billion | 5.07 Billion | 5.08 Billion | 4.86 Billion |
| Selling, General and Administrative Expenses | 5.5 Billion | - | 4.62 Billion | 4.24 Billion | 4.24 Billion | 4.86 Billion |
| Research and Development Expenses | - | - | 866 Million | 825 Million | 834 Million | 790 Million |
| Other Expenses | - | 99 Million | 30 Million | 12 Million | 4 Million | 53 Million |
| Cost and Expenses | 21.1 Billion | 82.11 Billion | 20.71 Billion | 21.38 Billion | 20.3 Billion | 19.71 Billion |
| Operating Income | 2.52 Billion | 9.37 Billion | 1.71 Billion | 3.06 Billion | 2.12 Billion | 2.47 Billion |
| Interest Expense | 30 Million | 112 Million | 27 Million | 27 Million | 31 Million | 27 Million |
| Income Tax Expense | 1.01 Billion | 3.14 Billion | 779 Million | 859 Million | 620 Million | 891 Million |
| Earnings before Tax | 3.38 Billion | 11.9 Billion | 3.45 Billion | 3.27 Billion | 2.22 Billion | 2.96 Billion |
| Net Income | 2.37 Billion | 8.75 Billion | 2.67 Billion | 2.41 Billion | 1.59 Billion | 2.06 Billion |
| Earnings Per Share Basic | 78.07 | - | 83.60 | 73.50 | 48.71 | 63.02 |
| Earnings Per Share Diluted | 78.07 | - | 83.60 | 73.50 | 48.71 | 63.05 |
| Weighted Average Shares Outstanding | 30.35 Million | 32.61 Million | 31.99 Million | 32.82 Million | 32.82 Million | 32.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.35 Million | 32.61 Million | 31.99 Million | 32.82 Million | 32.82 Million | 32.81 Million |
| Gross Margin | 0.34 | 0.32 | 0.32 | 0.33 | 0.32 | 0.33 |
| EBIT Margin | 0.14 | - | 0.11 | 0.13 | 0.10 | 0.14 |
| Profit Margin | 0.10 | 0.10 | 0.12 | 0.10 | 0.07 | 0.09 |
| EBITDA | 3.35 Billion | - | 2.55 Billion | 3.2 Billion | 2.25 Billion | 3.02 Billion |
| Earnings Before Tax Margin | 0.11 | 0.10 | 0.08 | 0.13 | 0.09 | 0.11 |
8059
0KCS
INDAG
AMARIN
GNE
SCCG